Potential drug-drug interactions on in-patient medication prescriptions at Mbarara Regional Referral Hospital (MRRH) in western Uganda: Prevalence, clinical importance and associated factors

African Health Sciences

Volumn 11, Issue 3, 2011, Pages 499-507

  Lubinga, S J ^a   Uwiduhaye, E ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Chart review; Drug drug interactions; Pharmaco epidemiology; Prevalence

Indexed keywords

CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PRESCRIPTION DRUG;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COMORBIDITY; CONNECTIVE TISSUE DISEASE; DEMOGRAPHY; DRUG INTERACTION; ENDOCRINE DISEASE; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; METABOLIC DISORDER; MUSCULOSKELETAL DISEASE; NEOPLASM; NUTRITIONAL DISORDER; PHARMACODYNAMICS; PRESCRIPTION; PREVALENCE; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; UGANDA; AGED; CHILD; DRUG CONTRAINDICATION; INFANT; MEDICATION ERROR; MIDDLE AGED; NEWBORN; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICATION ERRORS; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PRESCRIPTION DRUGS; PREVALENCE; RETROSPECTIVE STUDIES; UGANDA; YOUNG ADULT;

EID: 84861322425     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Stockley HI, editor. Stockley's Drug Interactions. 5th ed. London, Chicago: The Pharmaceutical Press; 2001.
2. Doubova Dubova SV, Reyes-Morales H, Torres-Arreola Ldel P, Suarez-Ortega M. Potential drug-drug and drug-disease interactions in prescriptions for ambulatory patients over 50 years of age in family medicine clinics in Mexico City. BMC Health Serv Res. 2007;7:147.
3. Gagne JJ, Maio V, Rabinowitz C. Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy. J Clin Pharm Ther. 2008 Apr;33(2):141-151.
4. Glintborg B, Andersen SE, Dalhoff K. Drugdrug interactions among recently hospitalized patients-frequent but mostly clinically insignificant. Eur J Clin Pharmacol. 2005 Oct;61(9):675-681.
5. Riechelmann RP, Tannock IF, Wang L, Saad ED, Taback NA, Krzyzanowska MK. Potential drug interactions and duplicate prescriptions among cancer patients. J Natl Cancer Inst. 2007 Apr 18;99(8):592-600.
6. Vonbach P, Dubied A, Krahenbuhl S, Beer JH. Prevalence of drug-drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Intern Med. 2008 Oct;19(6):413-420.
7. Becker ML, Kallewaard M, Caspers PW, Visser LE, Leufkens HG, Stricker BH. Hospitalisations and emergency department visits due to drugdrug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):641-651.
8. Jankel CA, McMillan JA, Martin BC. Effect of drug interactions on outcomes of patients receiving warfarin or theophylline. Am J Hosp Pharm. 1994 Mar 1;51(5):661-666.
9. Moura CS, Acurcio FA, Belo NO. Drug-drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12(3):266-272.
10. Espino DV, Bazaldua OV, Palmer RF, Mouton CP, Parchman ML, Miles TP, et al. Suboptimal medication use and mortality in an older adult community-based cohort: results from the Hispanic EPESE Study. J Gerontol A Biol Sci Med Sci. 2006 Feb;61(2):170-175.
11. Bjerrum L, Gonzalez Lopez-Valcarcel B, Petersen G. Risk factors for potential drug interactions in general practice. Eur J Gen Pract. 2008;14(1):23-29.
12. Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9(3):427-433.
13. Kigen G, Kimaiyo S, Nyandiko W, Faragher B, Sang E, Jakait B, et al. Prevalence of Potential Drug-Drug Interactions Involving Antiretroviral Drugs in a Large Kenyan Cohort. PLoS ONE. 2011;6(2):e16800.
14. Perkins NA, Murphy JE, Malone DC, Armstrong EP. Performance of drug-drug interaction software for personal digital assistants. Ann Pharmacother. 2006 May;40(5):850-855.
15. Dallenbach MF, Bovier PA, Desmeules J. Detecting drug interactions using personal digital assistants in an out-patient clinic. QJM. 2007 Nov;100(11):691-697.
16. Panomvana Na Ayudhya D, Thanompuangseree N, Tansuphaswadikul S. Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. Clin Pharmacokinet. 2004;43(11):725-732.
17. Piper JM, Ray WA, Daugherty JR, Griffin MR. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Ann Intern Med. 1991 May 1;114(9):735-740.
18. Kataoka H, Horie Y, Koyama R, Nakatsugi S, Furukawa M. Interaction between NSAIDs and steroid in rat stomach: safety of nimesulide as a preferential COX-2 inhibitor in the stomach. Dig Dis Sci. 2000 Jul;45(7):1366-1375.
19. Mignat C, Unger T. ACE inhibitors. Drug interactions of clinical significance. Drug Saf. 1995 May;12(5):334-347.
20. Bicket DP. Using ACE inhibitors appropriately. Am Fam Physician. 2002 Aug 1;66(3):461-468.
21. Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebocontrolled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987 Nov;107(5):628-635.
22. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994 Aug 15;121(4):289-300.
23. Favre L, Glasson P, Riondel A, Vallotton MB. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man. Clin Sci (Lond). 1983 Apr;64(4):407-415.
24. Herchuelz A, Derenne F, Deger F, Juvent M, Van Ganse E, Staroukine M, et al. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance. J Pharmacol Exp Ther. 1989 Mar;248(3):1175-1181.
25. Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Prim Health Care. 2003 Sep;21(3):153-158.